Latest Headlines

31. FDA Clears Thermo Scientific EliA RNA Pol III And EliA Rib-P Tests For Use In U.S 6/9/2022

    Thermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. Food & Drug Administration (FDA) for aiding in the diagnosis of Systemic Sclerosis (SSc; scleroderma) and Systemic Lupus Erythematosus (SLE).

32. LabVantage Solutions Adds Mixed Reality Technology To Its Advanced LIMS Platform 6/9/2022

    LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, announced it has signed a global cooperation agreement with Holo4Labs (H4L).

33. Hamilton And Bionano Genomics Announce World’s First Ultra High Molecular Weight DNA Extraction Automation Solution For OGM 6/9/2022

    Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the collaborative development of the Long String VANTAGE for the isolation of Ultra High Molecular Weight (UHMW) DNA for use in optical genome mapping (OGM).

34. The Sample Storage Tube With The Best Volume To Height Ratio 6/9/2022

    The Micronic 0.80ml Tube with External Thread provides research labs the best volume to height ratio compared to similar sample storage tubes in the market. With its mere 38.3mm height the 0.80ml tube offers 0.75ml working volume at ambient temperature.

35. Proscia’s Concentriq Dx Attains CE Mark Under IVDR For Use In Primary Diagnosis 6/8/2022

    Proscia, a leader in digital and computational pathology solutions, today announced that its Concentriq Dx platform has been certified under the new In Vitro Diagnostic Regulation (IVDR) for use in primary diagnosis.

36. Grifols Procleix Plasmodium Assay Receives CE Mark, A First For Malaria Blood Screening 6/8/2022

    Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a global leader in the development of plasma-derived therapies and the development of innovative diagnostic solutions, today announced that its Procleix Plasmodium Assay has obtained the CE mark, the first for an automated nucleic acid test (NAT) system specifically validated for screening blood donors for malaria.

37. LumiraDx Receives CE Mark For Two Multiplex Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete And LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete 6/8/2022

    LumiraDx Limited (Nasdaq: LMDX) today announced that it has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete. These high-sensitivity and high-throughput tests help to expand testing capabilities across the globe.

38. CerTest Biotec And BD Announce Collaboration On Molecular Diagnostic Test For Monkeypox 6/8/2022

    CerTest Biotec and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration to develop a molecular diagnostic test for the Monkeypox virus.

39. Thermo Fisher Scientific Updates Applied Biosystems QuantStudio 5 Dx Real-Time PCR System To Comply With IVDR Regulations 6/7/2022

    To help molecular diagnostic manufacturers and clinical testing laboratories adapt to higher-standard In Vitro Diagnostic Requirements (IVDR) now in effect in the European Union, Thermo Fisher Scientific is offering an IVDR version of the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System globally.

40. Kindbody Acquires Leading Genomics Company Phosphorus Labs, Will Add Genetic Testing And Carrier Screening To Its End-To-End Care Delivery Model 6/7/2022

    Kindbody, a leading fertility and family-building benefits provider for employers offering comprehensive virtual and in-person care, announced today the acquisition of Phosphorus Labs, a leading preventative genomics company.